Mezzanine Management sells Amethyst to The Rohatyn Group

Mezzanine Management has realized its investment in Romanian radiotherapy business Amethyst through a sale of its stake to The Rohatyn Group. The five-year partnership generated a very strong multiple and private equity-like IRR for investors in AMC III. The firm’s two co-founders will co-control the business alongside the incoming investor with a view to continuing the firm’s fast-paced growth.

AMC initially backed the business in May 2014, providing a structured growth solution worth EUR 18.0 million and comprising both mezzanine and minority equity. The funds were used to support Amethyst’s local and international expansion, namely expanding into Poland, France, Italy and Austria during the partnership. Amethyst was founded in 2010 and today treats over 10,000 patients annually from its nine centers across Romania, France, Italy, Poland and Austria.